What The Study Did: Researchers evaluated the SARS-CoV-2 spike immunoglobin (Ig) G antibody levels after one and two doses of the Pfizer/BioNTech (BNT162b2) SARS-CoV-2 mRNA vaccine in previously infected individuals compared with those without previous
Authors: James Moy, M.D., of Rush University Medical Center in Chicago, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.19741?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080621
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
JAMA Network Open